A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients

Completed · Phase 2 · Has a placebo group

Conditions studied: Drooling

In brief

To determine safety, tolerability and preliminary efficacy of intraglandular injections of MYOBLOC for the treatment of sialorrhea in Parkinsons' Disease patients

Key facts

Study ID
NCT00515437
Run by
Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
People needed
54
Starts
2007-07-01
Expected to finish
2008-09-01
Last updated by the study team
2026-04-21

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.